Table 2.
Scale measures for the complete HARPdoc cohort
| Variable | n | Total score | Mean item score |
|---|---|---|---|
| HFS-II, total score | 97 | 51.2 ± 26.1 | 1.6 ± 0.8 |
| HFS-II, behaviour | 97 | 21.1 ± 11.9 | 1.4 ± 0.8 |
| HFS behaviour score <1.85, n (%) | 97 | 73 (75.3) | |
| HFS-II, worry | 97 | 30.2 ± 16.3 | 1.7 ± 0.9 |
| HFS worry score <0.92, n (%) | 97 | 20 (20.6) | |
| HFS factor, ran high | 97 | 6.2 ± 3.6 | 1.6 ± 0.9 |
| HFS factor, sought safety | 97 | 13.8 ± 8.0 | 1.7 ± 1.0 |
| HFS factor, felt restricted | 93 | 6.5 ± 5.9 | 1.1 ± 1.0 |
| HFS factor, worry | 96 | 20.2 ± 12.2 | 1.6 ± 1.0 |
| A2A, total score | 97 | 10.0 ± 5.4 | 0.8 ± 0.5 |
| A2A, hyperglycaemia avoidance prioritised | 97 | 5.9 ± 2.7 | 1.5 ± 0.7 |
| A2A, hypoglycaemia concern minimised | 97 | 2.5 ± 1.9 | 0.6 ± 0.5 |
| A2A, asymptomatic hypoglycaemia normalised | 97 | 1.7 ± 2.2 | 0.4 ± 0.6 |
| PAID score | 96 | 31.9 ± 20.1 | |
| ≥40 (severe diabetes distress), n (%) | 96 | 30 (31.3) | |
| HADS-A score | 97 | 7.5 ± 4.6 | |
| 0–7 (normal), n (%) | 97 | 49 (50.5) | |
| 8–10 (borderline abnormal), n (%) | 97 | 22 (22.7) | |
| 11–21 (abnormal), n (%) | 97 | 26 (26.8) | |
| HADS-D score | 97 | 5.9 ± 4.3 | |
| 0–7 (normal), n (%) | 97 | 63 (64.9) | |
| 8–10 (borderline abnormal), n (%) | 97 | 20 (20.6) | |
| 11–21 (abnormal), n (%) | 97 | 14 (14.4) | |
| HARPdoc clusters | |||
| High fear/low barriers, n (%) | 97 | 29 (29.9) | |
| Low fear/high barriers, n (%) | 97 | 68 (70.1) | |
Data are presented as mean ± SD or n (%)